Clinical Trials Sponsored by Manshadi Heart Institute, Inc.

Total 194 results

University of the Pacific
Manshadi Heart Institute, Inc.

Unknown

Glucose Differences Between the Left Arm and Right Arm in Diabetic Patients Using a Continuous Glucose Monitor

Diabetes

United States
Tabba Heart Institute
InnoTherapy Inc

Recruiting

Low Dose Heparin Factorial Trial

Radial Artery Occlusion

Pakistan
Tallikut Pharmaceuticals, Inc.
Montreal Heart Institute

Completed

Study Effect of VIA-2291 on Vascular Inflammation

Coronary Artery Disease

Canada, United States
Optina Diagnostics Inc.
Montreal Heart Institute

Recruiting

Optina Eye to Heart Connection

Coronary Artery Disease

Canada
Montreal Heart Institute
Ingenew Pharmaceuticals Inc.

Completed

Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) (Hesperidin)

Pain | Confusion | Covid19 | Nausea | Vomiting | Cough | Muscle Weakness | Fever | Headache | Anosmia | Sore Throat | Shortness of Breath | Pain, Joint | Pain, Chest | Irritable Mood | Pain, Abdominal | Pain, Muscle

Canada
Mayo Clinic
Miami Heart Research Institute Inc.

Not yet recruiting

HTN App for HTN Control and Cardiovascular Health Among African-Americans

Hypertension

United States
Ottawa Heart Institute Research Corporation
StepsCount Inc

Completed

Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians (PiezoRx)

Cardiovascular Disease

Canada
Innovaderm Research Inc.
Abbott; Montreal Heart Institute

Completed

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis | Coronary Atherosclerosis | Vascular Inflammation

Canada
VeraLight, Inc.
New Mexico Heart Institute, PA

Completed

A Study Comparing Skin Fluorescence to Coronary Artery Calcification (CACS)

Diabetes | Coronary Artery Calcification

United States
Minneapolis Heart Institute Foundation
Osprey Medical, Inc

Terminated

REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)

Chronic Total Occlusion of Coronary Artery

United States
Innovaderm Research Inc.
Abbott; Montreal Heart Institute

Completed

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Psoriasis | Coronary Atherosclerosis | Vascular Inflammation

Canada
Carelon Research
National Heart, Lung, and Blood Institute (NHLBI); Jarvik Heart, Inc.

Active, not recruiting

Pumps for Kids, Infants, and Neonates (PumpKIN)

Pediatric Heart Failure

United States
Kansas City Heart Rhythm Institute
Biosense Webster, Inc.

Terminated

Catheter Ablation of Arrhythmias to Improve CRT Response (ABLATE-CRT)

Arrhythmia, Cardiac

United States
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (RAPID GENE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Stable Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Jubilant DraxImage Inc.

Active, not recruiting

Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease (RUBY-DOSE)

Ischemic Heart Disease

Canada
AusculSciences Canada Inc.
Ottawa Heart Institute Research Corporation

Unknown

Evaluating Auscul-X, a Touch Free Digital Stethoscope

COVID-19

Canada
AusculSciences Canada Inc.
Ottawa Heart Institute Research Corporation

Unknown

A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Coronary Occlusion

Canada
Ottawa Heart Institute Research Corporation
Jubilant DraxImage Inc.

Completed

Rubidium Elution System Performance Testing (REST-PET)

Coronary Artery Disease

Canada
Ottawa Heart Institute Research Corporation
Spartan Bioscience Inc.

Completed

Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) (RAPID STEMI)

STEMI

Canada
SoundBite Medical Solutions, Inc.
Montreal Heart Institute; ethica Clinical Research Inc.

Withdrawn

Prospective Study of the SoundBite™ Crossing System in Complex Peripheral CTOs (PROSPECTORII)

Peripheral Arterial Occlusive Disease | Chronic Total Occlusion of Artery of the Extremities

Austria, Germany
Athersys, Inc
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction (MI-NSTEMI)

Heart Attack | NSTEMI

United States
Gregory Jones
Biosense Webster, Inc.

Completed

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation (ICE)

Atrial Fibrillation

United States
Sonavex, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae

Kidney Diseases | Arteriovenous Fistula

United States
REGENXBIO Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Homozygous Familial Hypercholesterolemia (HoFH)

United States, Canada, Italy, Netherlands
Thrombolex, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden (RESCUE)

Pulmonary Embolism

United States
Sonavex, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Automated 3D Ultrasound-based Surveillance of Arteriovenous Fistula Maturation for Post-operative Hemodialysis Patients

Arteriovenous Fistula | Arteriovenous Graft

United States
Thermedical, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

SERF VT Ablation Early Feasibility Study (EFS) (SERF VT EFS)

Heart Diseases | Cardiovascular Diseases | Ventricular Tachycardia | Arrythmia

United States
Clarassance, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)

Bronchopulmonary Dysplasia | Respiratory Distress Syndrome in Premature Infant

United States
PICS, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

A Treatment Study Comparing Two Non-Drug, Self-Help Treatment of Chronic Insomnia.

Insomnia

United States
Synvista Therapeutics, Inc
National Institutes of Health (NIH); National Heart and Lung Institute

Completed

The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension

Cardiovascular Disease

United States
Hillhurst Biopharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Anemia, Sickle Cell

United States
Saint Luke's Health System
Piedmont Heart Institute, Inc., Atlanta, GA

Active, not recruiting

Outcomes of Surgically Ineligible Patients With Multivessel CAD (OPTIMUM)

Coronary Artery Disease

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Measurement of Cardiac Output and Intravascular Volume Status in Children Using COstatus (SH)

Intensive Care

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass

Cardiac Output

United States
Menssana Research, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Heartsbreath Test for Heart Transplant Rejection (Heartsbreath)

Heart Transplant Rejection

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique (BCM)

Cardiac Output

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation

Cardiac Output | Venoarterial Extracorporeal Membrane Oxygenation | Venovenous Extracorporeal Membrane Oxygenation | Recirculation | Oxygenator Blood Volume

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children

Cardiac Output

United States
Hillhurst Biopharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Anemia, Sickle Cell

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Measurement of Cardiac Output Before and After Cardiopulmonary Bypass.

Cardiac Output

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparison of Cardiac Output Measured by Ultrasound Dilution Method and Pulmonary Artery Thermodilution Technique

Cardiac Disease | Post Surgery Patients

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Measurement of Recirculation During Venovenous Extracorporeal Membrane Oxygenation (VV ECMO)

Venovenous Extracorporeal Membrane Oxygenation | Recirculation

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique (CH)

Neonatal Intensive Care

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients (GCH)

Cardiac Output

United States
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Measurement of Cardiac Output and Blood Volumes (WSU)

Cardiac Output

United States
ISA Associates, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

COPing With Shift Work - Web Based Program for Police Officers

Stress | Sleep Disorders

United States
Menssana Research, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Breath Test for Early Detection of Lung Cancer

Lung Neoplasms

United States
Profusa, Inc.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Recruiting

Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2

Peripheral Artery Disease

United States
EpiDestiny, Inc.
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Recruiting

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Sickle Cell Disease

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.; RTI International and other collaborators

Withdrawn

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial (PHLO)

Venous Thrombosis | Deep Vein Thrombosis | Post-Thrombotic Syndrome

Clinical Trials Sponsored by Manshadi Heart Institute, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations